[Clinical evaluation of chorei-to and chorei-to-go-shimotsu-to in patients with lower urinary tract symptoms].
[Clinical evaluation of chorei-to and chorei-to-go-shimotsu-to in patients with lower urinary tract symptoms].
复制标题
[chorei-to 和chorei-to-go-shimotsu-to 在下尿路症状患者中的临床评价]。
DOI：
--
复制
发表时间：
1988
期刊：
影响因子：
--
通讯作者：
M. Maekawa
中科院分区：
文献类型：
--
作者：
A. Horii;M. Maekawa
30 名主诉有下尿路症状但无脓尿的患者口服 Chorei-to。尿频有效率92.9%，排尿痛有效率85.8%，排尿不适有效率85.7%。总有效率76.0%。没有观察到不良影响。因此，Choreito被认为是治疗下尿路症状患者的有效药物。有相同症状的患者尝试了Choreito-go-shimotsu-to，其有效率达80%，但有2名患者出现上腹痛等不良反应。这两种药物被认为对患有下尿路症状的患者有效。
Chorei-to was administered orally to 30 patients who complained of lower urinary tract symptoms without pyuria. Efficacy rate of pollakisuria was 92.9%, miction pain 85.8%, and voiding discomfort 85.7%. Total efficacy rate was 76.0%. No untoward effect was observed. Therefore, Choreito was thought to be an effective drug for the patients with lower urinary tract symptoms. Patients with the same symptoms tried Choreito-go-shimotsu-to, and its efficacy rate turned out to be 80%, but untoward effect such as epigastraligia was observed on 2 patients. These 2 drugs are thought to be effective on patients suffering from lower urinary tract symptoms.